Albert D. Fraser was born in Fredericton, New Brunswick, Canada and received his Ph.D. in biochemistry at Boston University, USA in 1976. He was a post-doctoral fellow in Clinical Biochemistry at the Banting Institute, Faculty of Medicine, University of Toronto from 1976-78 and was funded by an O’Brien Foundation Fellowship.
Dr. Fraser received professional certification from the Canadian Academy of Clinical Biochemistry, the American Board of Clinical Chemistry (Toxicological Chemistry) and the American Board of Forensic Toxicology (Forensic Toxicology). He was trained as a laboratory inspector for the US National Institute on Drug Abuse drug testing certification programme (now administered by the Substance Abuse and Mental Health Services Administration – SAMHSA).
Albert was the Director of the Therapeutic Drug Monitoring/Clinical & Forensic Toxicology Laboratory, Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia for 25 years. He was also Professor of Pathology, Faculty of Medicine and College of Pharmacy at Dalhousie University. In 2007, he was appointed Head of Biochemistry and Toxicology at Atlantic Health Sciences Corporation in Saint John, NB.
His clinical and research activities include analysis of drugs of abuse in biological fluids and clinical pharmacokinetic studies of immunosuppressant drugs used in organ transplantation and anticonvulsant drugs for seizure control in children.
He was Clinical Head of Biochemistry, Laboratory Medicine at Saint John Regional Hospital, Horizon Health Network and Provincial Forensic Toxicologist for the Office of the Chief Coroner, Province of New Brunswick from 2007 - December 2013. Currently, he is a consultant forensic toxicologist to the Correctional Service of Canada, Canadian Nuclear Safety Commission and advisor to the Canadian Centre for Ethics in Sport.
Left to right: Dr. Albert Fraser (1976) with Dr. Daniel Bourgeois (1991)
Photo taken at the O’Brien Foundation Reception at Government House